The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study
Open accessAbstract
Summary Background: Older adults with advanced cancer are at high risk for treatment toxicity. Geriatric assessment (GA) evaluates aging-related domains and guides management. We examined whether a GA intervention can reduce serious toxicity in older patients with advanced cancer receiving high risk treatment (e.g., chemotherapy). Methods: In this cluster randomized trial, we enrolled patients aged ≥ 70 with incurable solid tumors or lymphoma and at least one impaired GA domain starting a new treatment regimen. Community oncology practice clusters across the United States (n=40) were randomized to intervention (oncologists received a tailored GA summary and management recommendations) or usual care. The primary outcome was the proportion of patients who experienced any grade 3–5 toxicity (NCI’s Common Terminology Criteria for Adverse Events V4.0) over 3 months. Practice staff prospectively captured toxicities; blinded oncology clinicians reviewed medical records to verify. Secondary outcomes included overall survival (OS), treatment intensity, and GA outcomes. Trial Registration: NCT02054741 Findings: From 2014–19, we enrolled 718 patients. Age (mean 77·2 years), sex (43·3% female), number of impaired GA domains (median 4·5/8), and treatment (chemotherapy 88·2%) did not differ by arm. More patients in intervention were Black versus other race (11·5% vs 3·3%, p<0·01) and had prior chemotherapy (30·8% vs 22·7%, p=0·02). A lower proportion of patients in intervention experienced grade 3–5 toxicity (177/349; 50·7%) than in usual care (263/369; 71·2%); relative risk (RR) was 0·74 (95% CI: 0·64–0·86; p<0·001). While more patients in intervention received reduced intensity treatment at cycle 1, OS was not different by arm at 6 months. Patients in intervention experienced fewer falls over 3 months (11·7% vs 20·7%; RR 0·58, p<0·01) and had more medications discontinued (mean adjusted difference 0·14, p=0·02). Interpretation: A GA intervention for older patients with advanced cancer reduced serious toxicity from cancer treatment without compromising OS. Funding: National Cancer Institute
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study
Hurria, A., Togawa, K., Mohile, S. G., Owusu, C., Klepin, H. D., Gross, C. P., Lichtman, S. M., Gajra, A., Bhatia, S., Katheria, V., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.7625 · Cited by 1,841
Self-citationWildiers, H., Heeren, P., Puts, M., Topinkova, E., Janssen-Heijnen, M. L. G., Extermann, M., Falandry, C., Artz, A., Brain, E., Colloca, G., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.8347 · Cited by 1,831
Self-citationUnderstanding the Treatment Preferences of Seriously Ill Patients
Fried, T. R., Bradley, E. H., Towle, V. R., & Allore, H. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa012528 · Cited by 1,522
Mohile, S. G., Dale, W., Somerfield, M. R., Schonberg, M. A., Boyd, C. M., Burhenn, P. S., Canin, B., Cohen, H. J., Holmes, H. M., Hopkins, J. O., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.8687 · Cited by 1,479
Self-citationSedrak, M. S., Freedman, R. A., Cohen, H. J., Muss, H. B., Jatoi, A., Klepin, H. D., Wildes, T. M., Le‐Rademacher, J. G., Kimmick, G. G., Tew, W. P., et al. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21638 · Cited by 471
Self-citationSeymour, M. T., Thompson, L. C., Wasan, H. S., Middleton, G., Brewster, A. E., Shepherd, S. F., O'Mahony, M. S., Maughan, T. S., Parmar, M., & Langley, R. E. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60399-1 · Cited by 419
Corre, R., Greillier, L., Le Caër, H., Audigier-Valette, C., Baize, N., Bérard, H., Falchero, L., Monnet, I., Dansin, E., Vergnenègre, A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.5839 · Cited by 403
US Preventive Services Task Force, Grossman, D. C., Curry, S. J., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2018) · JAMA · doi:10.1001/jama.2018.3097 · Cited by 332
Mohile, S. G., Epstein, R. M., Hurria, A., Heckler, C. E., Canin, B., Culakova, E., Duberstein, P., Gilmore, N., Xu, H., Plumb, S., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2019.4728 · Cited by 301
Self-citationMohile, S. G., Velarde, C., Hurria, A., Magnuson, A., Lowenstein, L., Pandya, C., O'Donovan, A., Gorawara-Bhat, R., & Dale, W. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0137 · Cited by 279
Self-citation
Cited by
Kim, D. H., & Rockwood, K. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2301292 · Cited by 824
Dale, W., Klepin, H. D., Williams, G. R., Alibhai, S. M. H., Bergerot, C., Brintzenhofeszoc, K., Hopkins, J. O., Jhawer, M. P., Katheria, V., Loh, K. P., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00933 · Cited by 517
Self-citationA meta-analysis on the role older adults with cancer favour in treatment decision making
van der Waal, M. S., Seghers, N., Welsing, P. M. J., van Huis, L. H., Emmelot-Vonk, M. H., & Hamaker, M. E. (2023) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2022.09.012 · Cited by 7
Metadata
- Authors
- Mohile, S. G., Mohamed, M. R., Xu, H., Culakova, E., Loh, K. P., Magnuson, A., Flannery, M. A., Obrecht, S., Gilmore, N., Ramsdale, E., Dunne, R. F., Wildes, T., Plumb, S., Patil, A., Wells, M., Lowenstein, L., Janelsins, M., Mustian, K., Hopkins, J. O., Berenberg, J., Anthony, N., & Dale, W.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2021-11
- Volume
- 398
- Issue
- 10314
- Pages
- 1894-1904
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W3209480926
- Cited by
- 602
- References
- 31
- FWCI
- 45.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. https://app.cochat.ai/papers/10.1016/s0140-6736(21)01789-x
- The paper
- Mohile, S. G., Mohamed, M. R., Xu, H., Culakova, E., Loh, K. P., Magnuson, A., Flannery, M. A., Obrecht, S., Gilmore, N., Ramsdale, E., Dunne, R. F., Wildes, T., Plumb, S., Patil, A., Wells, M., Lowenstein, L., Janelsins, M., Mustian, K., Hopkins, J. O., . . . Dale, W. (2021). Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. The Lancet. https://doi.org/10.1016/s0140-6736(21)01789-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.